+499.5%
MRNA vs ENPH
-1.9%
+501.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ENPH | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +0.2% | -2.4% | -2.3% |
| 7D | +5.5% | -2.4% | +7.8% | +6.1% |
| 30D | +158.7% | -6.6% | +165.4% | +164.9% |
| 3M | +182.1% | -46.8% | +228.9% | +211.4% |
| 6M | +151.8% | -14.7% | +166.6% | +155.1% |
| YTD | +393.6% | +13.5% | +380.1% | +352.1% |
| 1Y | +499.5% | -0.4% | +499.9% | +470.3% |
| All | +499.5% | -1.9% | +501.4% | +470.3% |
Cumulative growth
Daily Returns
Daily percentage return beside ENPH.
Daily Out/Under-Performance
Portfolio return minus ENPH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ENPH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ENPH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling